Abstract:Novel tacrine–donepezil hybrids were designed and synthesized. The compounds exhibited cholinesterase (ChE) inhibitory activity at the low micromolar level, neuroprotective effect on SH‐SY5Y cells, and noncytotoxicity on HepG2 cells, at similar concentrations to their ChE inhibitory activity. Compounds H4, H16, H17, and H24 stand out for their promising biological profile. A series of tacrine–donepezil hybrids were synthesized as potential multifunctional anti‐Alzheimer's disease (AD) compounds. For this purpose, tacrine and the benzylpiperidine moiety of donepezil were fused with a hydrazone group to achieve a small library of tacrine–donepezil hybrids. In agreement with the design, all compounds showed inhibitory activity toward both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50 values in the low micromolar range. Kinetic studies on the most potent cholinesterase (ChE) inhibitors within the series showed a mixed‐type inhibition mechanism on both enzymes. Also, the docking studies indicated that the compounds inhibit ChEs by dual binding site (DBS) interactions. Notably, tacrine–donepezil hybrids also exhibited significant neuroprotection against H2O2‐induced cell death in a differentiated human neuroblastoma (SH‐SY5Y) cell line at concentrations close to their IC50 values on ChEs and showed high to medium blood–brain barrier (BBB) permeability on human cerebral microvascular endothelial cells (HBEC‐5i). Besides, the compounds do not cause remarkable toxicity in a human hepatocellular carcinoma cell line (HepG2) and SH‐SY5Y cells. Additionally, the compounds were predicted to also have good bioavailability. Among the tested compounds, H4, H16, H17, and H24 stand out with their biological profile. Taken together, the proposed novel tacrine–donepezil scaffold represents a promising starting point for the development of novel anti‐ChE multifunctional agents against AD.

Novel multipotent phenylthiazole-tacrine hybrids for the inhibition of cholinesterase activity, β-amyloid aggregation and Ca²⁺ overload.

Design, Synthesis and Evaluation of Novel Tacrine-Multialkoxybenzene Hybrids As Dual Inhibitors for Cholinesterases and Amyloid Beta Aggregation

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.

Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease.

Novel Tacrine-Benzofuran Hybrids As Potent Multitarget-Directed Ligands for the Treatment of Alzheimer'S Disease: Design, Synthesis, Biological Evaluation, and X-Ray Crystallography

Design, Synthesis and Evaluation of Novel Tacrine-Rhein Hybrids As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.

Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids As Multifunctional Drug Candidates Against Alzheimer’s Disease

Synthesis and Pharmacological Evaluation of Multifunctional Tacrine Derivatives Against Several Disease Pathways of AD

Synthesis and Evaluation of Heterobivalent Tacrine Derivatives As Potential Multi-Functional Anti-Alzheimer Agents

Novel 1-phenyl-3-hydroxy-4-pyridinone derivatives as Multifunctional Agents for the therapy of Alzheimer's Disease.

Design, Synthesis and Evaluation of Novel Tacrine Coumarin Hybrids As Multifunctional Cholinesterase Inhibitors Against Alzheimer'S Disease

Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties.

Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease

Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.

Design, Synthesis and Biological Evaluation of Multifunctional Tacrine-Curcumin Hybrids As New Cholinesterase Inhibitors with Metal Ions-Chelating and Neuroprotective Property

Novel multifunctional tacrine–donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies

Syntheses of Coumarin–tacrine Hybrids As Dual-Site Acetylcholinesterase Inhibitors and Their Activity Against Butylcholinesterase, Aβ Aggregation, and Β-Secretase

Tacrine-Flurbiprofen Hybrids As Multifunctional Drug Candidates for the Treatment of Alzheimer's Disease

O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation.